drugset / Trial / NCT04065932

A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets

NCT04065932

Phase 1 Completed 33 enrolled Bristol-Myers Squibb
RandomizedParallel-groupOpen-labelTreatment

Summary

A Study to Determine the Drug Level Profile of Different formulations of BMS-986165 Tablets

Timeline

Start
2019-08-22
Primary completion
2019-12-08
Completion
2019-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule
Background Famotidine Other / unclassified

Indications